Pre-tax margin is the percentage of revenue left as profit after every expense except income tax. It is income before income tax divided by revenue, and the table shows both amounts beside the percentage. It sits between operating margin and net margin: it includes interest and other non-operating items but not the tax charge, so the gap down to net margin is the tax burden. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
Indivior Pharmaceuticals, Inc. pre-tax margin for the quarter ending 2026-06-30 was 46.65%, a 127.22% increase year-over-year.
Indivior Pharmaceuticals, Inc. pre-tax margin for the quarter ending 2026-03-31 was 36.28%, a 63.56% increase year-over-year.
Indivior Pharmaceuticals, Inc. pre-tax margin for the quarter ending 2025-12-31 was 22.63%, a 78.03% increase year-over-year.
Indivior Pharmaceuticals, Inc. pre-tax margin for the quarter ending 2025-09-30 was 11.78%, a 20.58% increase year-over-year.
Indivior Pharmaceuticals, Inc. pre-tax margin for fiscal 2025 was 19.29%, a 1045.81% increase from fiscal 2024.
Indivior Pharmaceuticals, Inc. pre-tax margin for fiscal 2024 was 1.68%, a change of 14.95% from fiscal 2023.
Indivior Pharmaceuticals, Inc. pre-tax margin for fiscal 2023 was -13.27%, a change of -3.39% from fiscal 2022.
Indivior Pharmaceuticals, Inc. pre-tax margin for fiscal 2022 was -9.88%.